Linda Yaccarino Appointed CEO of AI Health Tech Pioneer eMed
Linda Yaccarino Appointed CEO of AI Health Tech Pioneer eMed
Linda Yaccarino, formerly CEO of X, has been named the new chief executive of eMed Population Health, an innovative AI startup. The company is developing a cutting-edge tech platform specifically for patients utilizing GLP-1 medications, a class of drugs like Ozempic used for weight management and diabetes treatment.
Despite her background primarily in advertising at NBCUniversal and her recent two-year tenure at X, where she notably boosted ad revenue, eMed sought Yaccarino for her “undeniable ability to negotiate new partnerships.” Her high profile in the tech industry following her role at X is also expected to draw significant attention to the burgeoning health tech firm.
eMed previously gained recognition for its platform supporting at-home COVID-19 rapid antigen tests. Now, the company is pivoting its focus to the rapidly growing GLP-1 market, aiming to redefine healthcare outcomes through its groundbreaking services. “To be a leader in today’s healthcare marketplace, companies need to have a fearless tenacity,” Yaccarino stated, expressing confidence in eMed’s position to lead innovation in global healthcare.
Disclaimer: This content is aggregated from public sources online. Please verify information independently. If you believe your rights have been infringed, contact us for removal.